Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Leslie Citrome, MD, MPH, and Joseph P. McEvoy, MD, discuss clinical assessment and diagnosis of tardive dyskinesia (TD). They review using the AIMS exam for identification of dyskinesia in patients in both the clinical setting and via telepsychiatry. They also review how often to perform the AIMS exam, how to assess the results, and why it is important.
Leslie Citrome, MD, MPH
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York
Joseph P. McEvoy, MD
Psychiatry and Health Behavior
Greg Mattingly, MD, and Manish Jha, MD, review the latest available clinical data for emerging therapy options for tardive dyskinesia, from Clinical Care Options (CCO)
Clinical Care Options (CCO) commentary by Thomas L. Schwartz, MD, on choosing the right atypical antipsychotic in bipolar I and bipolar II patients
Attention deficits in a bipolar patient with a history of cannabis use from Clinical Care Options (CCO)
Slides from a presentation that educates clinicians on innovations in managing essential tremor and dystonias.